These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18609315)

  • 61. Relative practical utility of the Minnesota Multiphasic Personality Inventory-2 Restructured Clinical Scales versus the Clinical Scales in a chronic pain patient sample.
    McCord DM; Drerup LC
    J Clin Exp Neuropsychol; 2011 Jan; 33(1):140-6. PubMed ID: 20665319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between Tomm performance and PAI validity scales in a mixed clinical sample.
    Whiteside DM; Dunbar-Mayer P; Waters DP
    Clin Neuropsychol; 2009 Apr; 23(3):523-33. PubMed ID: 18821137
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The cognitive risk profile for pain: development of a self-report inventory for identifying beliefs and attitudes that interfere with pain management.
    Cook AJ; Degood DE
    Clin J Pain; 2006 May; 22(4):332-45. PubMed ID: 16691085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury.
    Greve KW; Bianchini KJ; Love JM; Brennan A; Heinly MT
    Clin Neuropsychol; 2006 Sep; 20(3):491-512. PubMed ID: 16895861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predicting test of memory malingering and medical symptom validity test failure within a Veterans Affairs Medical Center: use of the Response Bias Scale and the Henry-Heilbronner Index.
    Whitney KA
    Arch Clin Neuropsychol; 2013 May; 28(3):222-35. PubMed ID: 23493404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Examination of the MMPI-3 over-reporting scales in a forensic disability sample.
    Tylicki JL; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2022 Oct; 36(7):1878-1901. PubMed ID: 33319631
    [No Abstract]   [Full Text] [Related]  

  • 67. Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2.
    Aguerrevere LE; Greve KW; Bianchini KJ; Meyers JE
    Arch Clin Neuropsychol; 2008; 23(7-8):831-8. PubMed ID: 18715751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of overreporting on MMPI-2-RF substantive scale score validity.
    Burchett DL; Ben-Porath YS
    Assessment; 2010 Dec; 17(4):497-516. PubMed ID: 20739584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
    Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
    Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
    [No Abstract]   [Full Text] [Related]  

  • 70. MMPI-2 indices of psychological disturbance and attention and memory test performance in head injury.
    Ross SR; Putnam SH; Gass CS; Bailey DE; Adams KM
    Arch Clin Neuropsychol; 2003 Dec; 18(8):905-6. PubMed ID: 14609584
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The latent structure of cognitive symptom exaggeration on the Victoria Symptom Validity Test.
    Frazier TW; Youngstrom EA; Naugle RI; Haggerty KA; Busch RM
    Arch Clin Neuropsychol; 2007 Feb; 22(2):197-211. PubMed ID: 17276652
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of psychopathology and demographic characteristics on MMPI-2 scale scores.
    Schinka JA; LaLone L; Greene RL
    J Pers Assess; 1998 Apr; 70(2):197-211. PubMed ID: 9697327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Faking the MMPI-2: utility of the Subtle-Obvious scales.
    Brems C; Harris K
    J Clin Psychol; 1996 Sep; 52(5):525-33. PubMed ID: 8877687
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The construct validity of the Lees-Haley Fake Bad Scale. Does this scale measure somatic malingering and feigned emotional distress?
    Butcher JN; Arbisi PA; Atlis MM; McNulty JL
    Arch Clin Neuropsychol; 2003 Jul; 18(5):473-85. PubMed ID: 14591444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Psychometric properties of the MMPI-2-RF Somatic Complaints (RC1) scale.
    Thomas ML; Locke DE
    Psychol Assess; 2010 Sep; 22(3):492-503. PubMed ID: 20822262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlates of the MMPI-2-RF in a college setting.
    Forbey JD; Lee TT; Handel RW
    Psychol Assess; 2010 Dec; 22(4):737-44. PubMed ID: 20804257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detecting malingering in traumatic brain injury and chronic pain: a comparison of three forced-choice symptom validity tests.
    Greve KW; Ord J; Curtis KL; Bianchini KJ; Brennan A
    Clin Neuropsychol; 2008 Sep; 22(5):896-918. PubMed ID: 18756391
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The utility and comparative incremental validity of the MMPI-2 and Trauma Symptom Inventory validity scales in the detection of feigned PTSD.
    Efendov AA; Sellbom M; Bagby RM
    Psychol Assess; 2008 Dec; 20(4):317-26. PubMed ID: 19086755
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A defensive response set and the relation between cognitive and emotional functioning: a replication.
    Putzke JD; Williams MA; Boll TJ
    Percept Mot Skills; 1998 Feb; 86(1):251-7. PubMed ID: 9530743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.